- Home
- MATX vs APLS Comparison
MATX vs APLS Comparison
Compare MATX & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATX
- APLS
- Stock Information
- Founded
- MATX 1882
- APLS 2009
- Country
- MATX United States
- APLS United States
- Employees
- MATX N/A
- APLS N/A
- Industry
- MATX Marine Transportation
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- MATX Consumer Discretionary
- APLS Health Care
- Exchange
- MATX Nasdaq
- APLS Nasdaq
- Market Cap
- MATX 3.5B
- APLS 3.5B
- IPO Year
- MATX N/A
- APLS 2017
- Fundamental
- Price
- MATX $106.11
- APLS $23.13
- Analyst Decision
- MATX Hold
- APLS Buy
- Analyst Count
- MATX 4
- APLS 20
- Target Price
- MATX $131.67
- APLS $34.11
- AVG Volume (30 Days)
- MATX 292.2K
- APLS 2.0M
- Earning Date
- MATX 10-29-2025
- APLS 11-04-2025
- Dividend Yield
- MATX 1.34%
- APLS N/A
- EPS Growth
- MATX 56.13
- APLS N/A
- EPS
- MATX 14.81
- APLS N/A
- Revenue
- MATX $3,464,800,000.00
- APLS $754,649,000.00
- Revenue This Year
- MATX N/A
- APLS $20.59
- Revenue Next Year
- MATX $0.87
- APLS N/A
- P/E Ratio
- MATX $7.23
- APLS N/A
- Revenue Growth
- MATX 8.75
- APLS 20.02
- 52 Week Low
- MATX $91.75
- APLS $16.10
- 52 Week High
- MATX $169.12
- APLS $37.84
- Technical
- Relative Strength Index (RSI)
- MATX 52.04
- APLS 34.12
- Support Level
- MATX $104.01
- APLS $23.47
- Resistance Level
- MATX $106.46
- APLS $28.97
- Average True Range (ATR)
- MATX 2.45
- APLS 1.08
- MACD
- MATX 0.39
- APLS -0.75
- Stochastic Oscillator
- MATX 61.89
- APLS 2.18
About MATX Matson Inc.
Matson Inc is engaged in providing ocean transportation and logistics services. The business segments of the company are Ocean Transportation which provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific, and Logistics segment which offers long haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.